Drug Profile
Research programme: secreted protein therapeutics - ARCA biopharma/Kyowa Kirin
Alternative Names: Wnt therapeutics programLatest Information Update: 16 Jul 2019
Price :
$50
*
At a glance
- Originator Kirin Brewery; Nuvelo
- Developer ARCA biopharma Inc
- Class Proteins
- Mechanism of Action Intercellular signalling peptide and protein stimulants; Wnt signalling pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Inflammatory bowel diseases; Mucositis
Most Recent Events
- 05 Oct 2012 Discontinued - Preclinical for Cancer in USA (IV)
- 05 Oct 2012 Discontinued - Preclinical for Inflammatory bowel disease in USA (IV)
- 05 Oct 2012 Discontinued - Preclinical for Mucositis in USA (IV)